These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30340569)

  • 41. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
    Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
    Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A population-based analysis of a rare oncologic entity: Malignant pancreatic tumors in children.
    Mylonas KS; Nasioudis D; Tsilimigras DI; Doulamis IP; Masiakos PT; Kelleher CM
    J Pediatr Surg; 2018 Apr; 53(4):647-652. PubMed ID: 28693851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidemiologic trends and prognostic risk factors of patients with pancreatic neuroendocrine neoplasms in the US: an updated population-based study.
    Lu L; Shang Y; Mullins CS; Zhang X; Linnebacher M
    Future Oncol; 2021 Feb; 17(5):549-563. PubMed ID: 33401958
    [No Abstract]   [Full Text] [Related]  

  • 44. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
    Anlauf M
    Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proposal of organ-specific subdivision of M component and staging system for metastatic pulmonary neuroendocrine tumor.
    Wen J; Chen J; Liu D; Chen D; Chen Y; Fan M; Lu B
    Lung Cancer; 2020 Oct; 148():86-93. PubMed ID: 32846318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
    Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
    Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation and comparison between current prognostication systems for pancreatic neuroendocrine neoplasms: A single-institution experience with 176 patients.
    Teo R; Goh BKP; Tai DWM; Allen JC; Lim TKH; Hwang JSG; Tan DM; Lee SY; Chan CY; Cheow PC; Chow PKH; Ooi LLPJ; Chung AYF; Ong S
    Surgery; 2017 May; 161(5):1235-1245. PubMed ID: 28111046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of WHO 2000 and WHO 2010 classifications of gastroenteropancreatic neuroendocrine tumors.
    Karakuş E; Helvacı A; Ekinci O; Dursun A
    Turk J Gastroenterol; 2014 Feb; 25(1):81-7. PubMed ID: 24918137
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.
    Bilimoria KY; Bentrem DJ; Ko CY; Ritchey J; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Aug; 110(4):738-44. PubMed ID: 17580363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement.
    Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
    Virchows Arch; 2010 Jun; 456(6):595-7. PubMed ID: 20422210
    [No Abstract]   [Full Text] [Related]  

  • 54. WHO 2010 classification of pancreatic endocrine tumors. is the new always better than the old?
    Ricci C; Casadei R; Taffurelli G; D'Ambra M; Monari F; Campana D; Tomassetti P; Santini D; Minni F
    Pancreatology; 2014; 14(6):539-41. PubMed ID: 25266640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the Prognostic Validity of the American Joint Committee on Cancer Staging Classification for Midgut Neuroendocrine Tumors.
    Yang JY; Baeg K; Martin JA; Wisnivesky J; Kim MK
    Pancreas; 2021 Nov-Dec 01; 50(10):e81-e82. PubMed ID: 35041348
    [No Abstract]   [Full Text] [Related]  

  • 56. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors.
    Wu L; Chen F; Chen S; Wang L
    Neuroendocrinology; 2018; 107(3):209-217. PubMed ID: 29920478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study.
    Gao S; Pu N; Liu L; Li C; Xu X; Wang X; Lou W
    J Cancer; 2018; 9(9):1698-1706. PubMed ID: 29760809
    [No Abstract]   [Full Text] [Related]  

  • 59. Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European Neuroendocrine Tumor Society staging systems.
    Shen C; Yin Y; Chen H; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
    Oncotarget; 2017 Mar; 8(13):22123-22134. PubMed ID: 27902460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Classification of pancreatic neuroendocrine tumours: Changes made in the 2017 WHO classification of tumours of endocrine organs and perspectives for the future].
    Scoazec JY; Couvelard A;
    Ann Pathol; 2017 Dec; 37(6):444-456. PubMed ID: 29169836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.